$UVSP Cashflow Statement | Understand Stock

$UVSP

$42.40 +$0.00 (0.0%) After hours

$UVSP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses
Depreciation of premises and equipment
Net gain on sales of investment securities
Net gain on mortgage banking activities
Bank owned life insurance income
Net amortization of investment securities premiums and discounts
Amortization, fair market value adjustments and capitalization of servicing rights
Net amortization (accretion) of acquisition accounting fair value adjustments
Stock-based compensation
Intangible expenses
Other adjustments to reconcile net income to cash used in by operating activities
Deferred tax expense (benefit)
Originations of loans held for sale
Proceeds from the sale of loans held for sale
Contributions to pension and other postretirement benefit plans
Decrease (increase) in accrued interest receivable and other assets
(Decrease) increase in accrued interest payable and other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Net cash paid due to acquisitions
Proceeds from sale of premises and equipment
Purchases of premises and equipment
Proceeds from maturities, calls and principal repayments of securities held-to-maturity
Proceeds from maturities, calls and principal repayments of securities available-for-sale
Proceeds from sales
Purchases of investment securities held-to-maturity
Purchases of investment securities available-for-sale
Proceeds from sales of equity securities
Purchases of money market mutual funds
Net decrease (increase) in other investments
Proceeds from sale of loans originally held-for-investment
Net increase in loans and leases
Proceeds from sales of foreclosed / repossessed assets
Purchases of bank owned life insurance
Proceeds from bank owned life insurance
Net cash used in investing activities
Cash flows from financing activities:
Net increase in deposits
Net increase (decrease) in short-term borrowings
Proceeds from issuance of long-term debt
Repayment of long-term debt
Proceeds from issuance of subordinated notes
Subordinated notes issuance costs
Repayment of subordinated notes
Payment of contingent consideration on acquisitions
Payment for shares withheld to cover taxes on vesting of restricted stock units
Purchases of treasury stock
Stock issued under dividend reinvestment and employee stock purchase plans
Proceeds from exercise of stock options
Cash dividends paid
Net cash provided by financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes, net of refunds
Non cash transactions:
Transfer of loans to other real estate owned
Transfer of leases to repossessed assets
Transfer of loans to loans held for sale
Contingent consideration recorded as goodwill

Comments